PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases
News
YouGov, on behalf of Bidwells, are carrying out a survey of the Tech sector.
The purpose of the study is to help the real estate sector and policy makers understand the requirements and preferences of organisations so they might better provide property and infrastructure for your industry in the future.
The survey looks at the location and property requirements of the tech sector overall. There are also some additional questions for companies, currently or potentially, working in the areas of health and life sciences.
Click here to view the May 2023 edition of The Meeting Place.
The University of Birmingham’s Clinical Immunology Service (CIS) is soon to become the anchor tenant at the forthcoming Precision Health Technology Accelerator (PHTA), after signing up to occupy ~10,000 sq ft of the custom-built flagship research facility.
Providing a comprehensive range of accredited lab services to facilitate the diagnosis of autoimmune and neuroimmunological disease, blood cancers, primary and secondary immunodeficiency, infections and allergy, the CIS receives more than 100,000 blood, marrow, urine and other samples per year.
Early-stage life sciences enterprises are set to benefit from a unique new collaboration between Birmingham’s Precision Health Technologies Accelerator (PHTA) and Oxford Science Enterprises (OSE).
The partnership will focus on helping high-growth health technology and life sciences companies to scale, primarily through access to high-quality lab and innovation space, while also catalysing cross-regional collaboration between academics and enterprises.
Stevenage, 18th May, 2023 – Kadans Science Partner (Kadans), the European leader in developing science and technology real estate, today announces the launch of Sycamore House, a new laboratory and office facility for innovative, high-growth life science companies and Kadans’ first completed development in the UK. By adding Sycamore House to the portfolio, Kadans is furthering its goal to create one strong knowledge-sharing ecosystem of science parks across Europe.
- Pharmanovia’s leading medicine brands to be combined with Closed Loop Medicine’s technology to provide dose optimized personalized therapies
- Global (ex-US) co-development and commercialization partnership to initially focus on next-generation drug + software product solutions for the treatment of hypertension
Accelerate@Babraham, the Babraham Research Campus’ programme supporting early-stage life science ventures, announces new cohort
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has launched a new in vitro model of the blood brain barrier (BBB) for research into neurodegenerative diseases.